Extensive cell and animal-based studies have focused on SOD1 biology in ALS [2], [3], however, these mutations only account for around 20% of familial ALS cases and approximately 2–3% of all ALS patients [4], [5]. Here, SOD1 is linked to amyotrophic lateral sclerosis.